BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 31590634)

  • 1. Cognitive impairments in patients with persistent symptoms attributed to Lyme disease.
    Berende A; Agelink van Rentergem J; Evers AWM; Ter Hofstede HJM; Vos FJ; Kullberg BJ; Kessels RPC
    BMC Infect Dis; 2019 Oct; 19(1):833. PubMed ID: 31590634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prolonged antibiotic treatment on cognition in patients with Lyme borreliosis.
    Berende A; Ter Hofstede HJM; Vos FJ; Vogelaar ML; van Middendorp H; Evers AWM; Kessels RPC; Kullberg BJ
    Neurology; 2019 Mar; 92(13):e1447-e1455. PubMed ID: 30796143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Objective cognitive performance and subjective complaints in patients with chronic Q fever or Q fever fatigue syndrome.
    Reukers DFM; Aaronson J; van Loenhout JAF; Meyering B; van der Velden K; Hautvast JLA; van Jaarsveld CHM; Kessels RPC
    BMC Infect Dis; 2020 Jun; 20(1):397. PubMed ID: 32503444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memory functioning in Lyme borreliosis.
    Ravdin LD; Hilton E; Primeau M; Clements C; Barr WB
    J Clin Psychiatry; 1996 Jul; 57(7):282-6. PubMed ID: 8666568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relations among indexes of memory disturbance and depression in patients with Lyme borreliosis.
    Barr WB; Rastogi R; Ravdin L; Hilton E
    Appl Neuropsychol; 1999; 6(1):12-8. PubMed ID: 10382566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating subjective cognitive impairment in the adult epilepsy clinic: Effects of depression, number of antiepileptic medications, and seizure frequency.
    Feldman L; Lapin B; Busch RM; Bautista JF
    Epilepsy Behav; 2018 Apr; 81():18-24. PubMed ID: 29455082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological dysfunction in chronic fatigue syndrome and the relation between objective and subjective findings.
    Rasouli O; Gotaas ME; Stensdotter AK; Skovlund E; Landrø NI; Dåstøl P; Fors EA
    Neuropsychology; 2019 Jul; 33(5):658-669. PubMed ID: 31169386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between self-reported cognitive difficulties, objective neuropsychological test performance and psychological distress in chronic pain.
    Baker KS; Gibson SJ; Georgiou-Karistianis N; Giummarra MJ
    Eur J Pain; 2018 Mar; 22(3):601-613. PubMed ID: 29160603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention impairment in motor functional neurological disorders: a neuropsychological study.
    Věchetová G; Nikolai T; Slovák M; Forejtová Z; Vranka M; Straková E; Teodoro T; Růžička E; Edwards MJ; Serranová T
    J Neurol; 2022 Nov; 269(11):5981-5990. PubMed ID: 35842882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
    Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
    J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and determinants of persistent symptoms after treatment for Lyme borreliosis: study protocol for an observational, prospective cohort study (LymeProspect).
    Vrijmoeth HD; Ursinus J; Harms MG; Zomer TP; Gauw SA; Tulen AD; Kremer K; Sprong H; Knoop H; Vermeeren YM; van Kooten B; Joosten LAB; Kullberg BJ; Hovius JWR; van den Wijngaard CC
    BMC Infect Dis; 2019 Apr; 19(1):324. PubMed ID: 30987580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of baseline cancer-related cognitive impairment in cancer patients scheduled for a curative treatment.
    Lycke M; Pottel L; Pottel H; Ketelaars L; Stellamans K; Van Eygen K; Vergauwe P; Werbrouck P; Goethals L; Schofield P; Boterberg T; Debruyne PR
    Psychooncology; 2017 May; 26(5):632-639. PubMed ID: 27338029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive functioning in late Lyme borreliosis.
    Krupp LB; Masur D; Schwartz J; Coyle PK; Langenbach LJ; Fernquist SK; Jandorf L; Halperin JJ
    Arch Neurol; 1991 Nov; 48(11):1125-9. PubMed ID: 1953395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Cognitive Outcomes of Clinical Phenotypes of Late-Life Depression.
    Riddle M; Potter GG; McQuoid DR; Steffens DC; Beyer JL; Taylor WD
    Am J Geriatr Psychiatry; 2017 Oct; 25(10):1123-1134. PubMed ID: 28479153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognition in Post-Treatment Lyme Disease and Major Depressive Disorder.
    Keilp JG; Corbera K; Gorlyn M; Oquendo MA; Mann JJ; Fallon BA
    Arch Clin Neuropsychol; 2019 Jun; 34(4):466-480. PubMed ID: 30418507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological profiles of breast cancer and brain tumor cohorts in Northeast Ontario, Canada.
    Mariani M; Collins MWG
    Support Care Cancer; 2018 Nov; 26(11):3801-3809. PubMed ID: 29774475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological test performance of former American football players.
    Alosco ML; Barr WB; Banks SJ; Wethe JV; Miller JB; Pulukuri SV; Culhane J; Tripodis Y; Adler CH; Balcer LJ; Bernick C; Mariani ML; Cantu RC; Dodick DW; McClean MD; Au R; Mez J; Turner RW; Palmisano JN; Martin B; Hartlage K; Cummings JL; Reiman EM; Shenton ME; Stern RA;
    Alzheimers Res Ther; 2023 Jan; 15(1):1. PubMed ID: 36597138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive impairment in patients with psoriasis: A matched case-control study.
    Innamorati M; Quinto RM; Lester D; Iani L; Graceffa D; Bonifati C
    J Psychosom Res; 2018 Feb; 105():99-105. PubMed ID: 29332640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subjective memory complaints, depressive symptoms and instrumental activities of daily living in mild cognitive impairment.
    Ryu SY; Lee SB; Kim TW; Lee TJ
    Int Psychogeriatr; 2016 Mar; 28(3):487-94. PubMed ID: 26555226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-report instruments of cognitive failures as screening tools for Subjective Cognitive Impairment in older adults.
    Papaliagkas V; Papantoniou G; Tsolaki M; Moraitou D
    Hell J Nucl Med; 2017; 20 Suppl():58-70. PubMed ID: 29324915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.